Successfully treated invasive pulmonary aspergillosis in a patient with diabetic ketoacidosis

We report herein a case of diabetic ketoacidosis associated with invasive aspergillosis that was successfully treated with liposomal amphotericin-B (L-AMB). Early intervention after confirming the diagnosis of invasive pulmonary aspergillosis is very important, and initiating early treatment with L-AMB can lead to a full recovery.

[1]  P. Aronowitz,et al.  Invasive Aspergillosis , 2013, Journal of General Internal Medicine.

[2]  F. Della Corte,et al.  Early diagnosis of invasive pulmonary aspergillosis in a young immunocompetent patient. , 2012, The new microbiologica.

[3]  A. Trompeo,et al.  Combination antifungal treatment of pseudomembranous tracheobronchial invasive aspergillosis: a case report , 2009, Intensive Care Medicine.

[4]  M. Yigla,et al.  Radiological findings of early invasive pulmonary aspergillosis in immune‐compromised patients , 2009, Hematological oncology.

[5]  R. Porcher,et al.  Therapeutic Outcome and Prognostic Factors of Invasive Aspergillosis in an Infectious Disease Department: A Review of 34 Cases , 2008, Infection.

[6]  J. Grizzanti,et al.  Diabetic ketoacidosis and invasive aspergillosis , 2007, Lung.

[7]  U. Yılmaz,et al.  Successful treatment of invasive pulmonary aspergillosis in an immunocompetent host , 2005, Respirology.

[8]  S. Janes,et al.  Invasive pulmonary aspergillosis in an insulin-dependent diabetic. , 1998, Respiratory medicine.

[9]  J. Perfect,et al.  NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. , 1994, The American journal of medicine.

[10]  J. Perfect,et al.  Erratum: NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis (American Journal of Medicine (August 1994) 97 (135-144)) , 1994 .

[11]  D. Speller.  New strategies in fungal disease , 1992 .

[12]  D. Mackenzie,et al.  Serodiagnosis of Aspergillosis , 1991 .

[13]  J. Hoekstra,et al.  Effect of epidemic influenza on ketoacidosis, pneumonia and death in diabetes mellitus: a hospital register survey of 1976-1979 in The Netherlands. , 1991, Diabetes research and clinical practice.

[14]  D. Denning,et al.  Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. , 1990, Reviews of infectious diseases.

[15]  R. Woestenborghs,et al.  The Clinical Pharmacokinetics of Itraconazole: An Overview , 1989, Mycoses.

[16]  F. Griffin,et al.  Invasive pulmonary aspergillosis in nonimmunocompromised, nonneutropenic hosts. , 1986, Reviews of infectious diseases.

[17]  M. Rinaldi.  Invasive aspergillosis. , 1983, Reviews of infectious diseases.

[18]  C. Horn,et al.  Invasive aspergillosis following post-influenzal pneumonia. , 1983, British journal of diseases of the chest.

[19]  W. Lee,et al.  Fungal infections in patients with acute leukemia. , 1982, The American journal of medicine.

[20]  J. Burke,et al.  Disseminated aspergillosis in a presumably immunocompetent host. , 1982, JAMA.

[21]  A. Schaffner,et al.  Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. , 1982, The Journal of clinical investigation.

[22]  R. Rubin,et al.  The Renal Transplant Patient with Fever and Pulmonary Infiltrates: Etiology, Clinical Manifestations, and Management , 1980, Medicine.

[23]  P. Walzer,et al.  Diffuse pulmonary infiltrates in immunosuppressed patients. Prospective study of 80 cases. , 1979, The American journal of medicine.

[24]  J. Aisner,et al.  Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. , 1977, Annals of internal medicine.

[25]  R. Greenman,et al.  Lung biopsy in immunocompromised hosts. , 1975, The American journal of medicine.

[26]  P. Watkins,et al.  Diabetic Ketoacidosis During the Influenza Epidemic , 1970, British medical journal.